IL31 and T-cell non-Hodgkin lymphoma: In addition, IL31 is highly expressed in hematological malignancies such as follicular lymphoma, germinal cancer derived B-cell malignancy, and T cell lymphoma, and was found to contribute to tumor growth via the STAT1/STAT3 signaling pathway [37].